Week 7: Module 5 – Sleep/Wake Disorders, Somatic Symptom and Related Disorders and Eating Disorders
Eating disorders are notoriously difficult to treat and there are only two of these disorders that have FDA approved psychopharmacologic treatment options.
Group 1:
Discuss bulimia nervosa (BN), anorexia nervosa (AN), and binge eating disorder (BED) recommended treatments, the rationale for the treatments, include the MOA and evidence for its use.
Group 2:
Discuss Restless Leg syndrome and Periodic Limb Syndrome. Include etiology and neurobiologic principles. Discuss treatments with emphasis on pharmacologic treatments. Don’t forget to include why and how these medications work to reduce symptoms by including the MOA, evidence for its use, and side effects along with patient education.
Group 3:
KL is a 79 yo man requesting assistance for “something to help with sleep”. His past medical history is significant for coronary artery disease and s/p CABG, hyperlipidemia, hypertension, major depressive disorder, and benign prostatic hypertrophy. He is taking the following medications: Aspirin 81 mg daily, Lisinopril 20 mg daily, Metoprolol succinate 100 mg daily, Simvastatin 20 mg daily, fluoxetine 40 mg hs, and doxazosin 4 mg hs. He admits to drinking 2 alcoholic drinks/night and denies smoking. Include in your discussion:
The differences in initial, middle, and terminal insomnia and how would you best choose pharmacologic treatment for each one of these based on the half-lives of each hypnotic?
Identify any secondary causes for insomnia.
What treatment plan do you recommend for KL’s insomnia? (Be specific with your recommendations-which hypnotic and why)
PLACE THIS ORDER OR A SIMILAR ORDER WITH ONLINE NURSING PAPERS TODAY AND GET AN AMAZING DISCOUNT